Inspiring. Insightful. Pragmatical.

The road to success and excellence is bumpy! We ask the experts for advice on how to tackle the roadblocks, master soft skills and become a leader!

Join our scientific team in the discussion of the 3 most clinically impactful papers of the month, the crème de la crème of our weekly top picks.

This month we’re discussing:

Electronic Health Record Alerts for Management of Heart Failure with Reduced Ejection Fraction in Hospitalized Patients: the PROMPT-AHF trial

https://doi.org/10.1093/eurheartj/ehad512

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial

https://doi.org/10.1001/jama.2023.20294

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial

https://doi.org/10.1001/jama.2023.16503

Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial

https://doi.org/10.1002/ejhf.3001

Scientific team: Ricardo Ladeiras Lopes, Mário Santos and João Sérgio Neves

Discover Medical Portfolio App weekly top picks - the latest and most relevant papers, curated by our team of experts!

https://linktr.ee/medicalportfolioapp

Inspiring. Insightful. Pragmatical.

The road to success and excellence is bumpy! We ask the experts for advice on how to tackle the roadblocks, master soft skills and become a leader!

This month we’re discussing four papers:

DOI: 10.1056/NEJMoa2306963

DOI: 10.1056/NEJMoa2303062

DOI: 10.1161/CIRCULATIONAHA.123.066485 

Title: Dapagliflozin in Patients with Heart Failure and Deterioration in Estimated Glomerular Filtration Rate to <25ml/min/1.73m2

DOI: 10.1016/j.jacc.2023.08.026

Scientific team: 

Ricardo Ladeiras Lopes, MD, PhD | Mário Santos MD, PhD |João Sérgio Neves, MD, PhD